Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

Summary

The purpose of this study is to evaluate the effectiveness of the modified Conjunctival Allergen Challenge (CAC) and observe how the produced allergic inflammation reacts to treatment with a proven ocular anti-inflammatory medication, Prednisolone, assessed by the following measures: Chronic Allergic Inflammation assessed using confocal microscopy Ocular itching Conjunctival redness

Timeline

Start

2012-11

Primary completion

2012-12

Completion

2012-12

Drugs

Indications